Neuren Pharmaceuticals | Umlaufvermögen

Aktienkurs
13.05
Täglich Wechseln
-0.39 -2.90%
Monatlich
-23.68%
Jährlich
-1.36%
Q1 Prognose
12.78




Umlaufvermögen Veränderung Datum
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Avita Medical AUD 36.25M 20.75M 2025-06
Clinuvel Pharmaceuticals AUD 222.06M 20.56M 2024-06
Dianthus Therapeutics USD 413.82M 150.22M 2025-09
Genetic Signatures AUD 47.98M 3.59M 2025-06
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Medical Developments International AUD 35.54M 2.13M 2025-06
Neuren Pharmaceuticals AUD 320.25M 79.08M 2025-06
Organon & Co USD 4.7B 82M 2025-09
Paradigm Biopharmaceuticals AUD 24.13M 8.16M 2025-06
PYC Therapeutics AUD 177.53M 115.4M 2025-06
Starpharma Holdings AUD 22.56M 3.69M 2025-06
Tectonic Therapeutic USD 273.24M 17.61M 2025-09
Telix Pharmaceuticals AUD 330.28M 67.73M 2025-12
Viatris USD 9.79B 162.2M 2025-12
Xeris Pharmaceuticals USD 224.02M 38.44M 2025-09


Neuren Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.